Prescription drug · UNAPPROVED DRUG OTHER
Phenobarbital Oral Solution (Phenobarbital oral) NDC 81033-163
Phenobarbital 20 mg/5mL · Solution · Oral · Kesin Pharma Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 81033-163-54 | 81033016354 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-163-54) / 5 mL in 1 CUP, UNIT-DOSE (81033-163-05)Marketed from Sep 3, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Phenobarbital Oral Solution
- Generic name (nonproprietary)
- phenobarbital oral
- Active ingredients
- Phenobarbital — 20 mg/5mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Kesin Pharma CorporationNDC labeler code 81033
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Identifiers
- Product ID 81033-163_3deab1f7-df73-3253-e063-6394a90a6503SPL ID 3deab1f7-df73-3253-e063-6394a90a6503SPL set ID 3deab1d0-2201-41a6-e063-6394a90a5dc0RxCUI 702519UNII YQE403BP4D
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N481033016354followed by a unit qualifier and the quantityPackage 81033-0163-54. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS USAGE A. Sedative B. Anticonvulsant - For the treatment of generalized and partial seizures.
Excerpt only. Read the full label for complete information.
About NDC 81033-163
- What is NDC 81033-163?
- 81033-163 is the product NDC for Phenobarbital Oral Solution (phenobarbital oral), Phenobarbital 20 mg/5mL solution, listed with the FDA by Kesin Pharma Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Phenobarbital Oral Solution (Phenobarbital Oral).
- What is the active ingredient?
- Phenobarbital.
- Who is the labeler?
- Kesin Pharma Corporation, NDC labeler code 81033. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Phenobarbital Oral Solution?
- 6 other product NDCs are listed under this name. See all Phenobarbital Oral Solution NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Phenobarbital Oral Solution products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Phenobarbital Oral Solutionphenobarbital oral | Phenobarbital 20 mg/5mL | SolutionOral | Ajenat Pharmaceuticals LLC | 82983-417 | 82983-0417-47 |
| Phenobarbital Oral Solutionphenobarbital oral | Phenobarbital 20 mg/5mL | SolutionOral | Kesin Pharma Corporation | 81033-164 | 81033-0164-47 |
| Phenobarbital Oral Solutionphenobarbital oral | Phenobarbital 20 mg/5mL | SolutionOral | BPI Labs LLC | 54288-163 | 54288-0163-47 |
| Phenobarbital Oral Solutionphenobarbital oral | Phenobarbital 60 mg/15mL | SolutionOral | PAI Holdings, LLC dba PAI Pharma | 0121-2826 | 00121-2826-50 |
| Phenobarbital Oral Solutionphenobarbital oral | Phenobarbital 30 mg/7.5mL | SolutionOral | PAI Holdings, LLC dba PAI Pharma | 0121-1884 | 00121-1884-50 |
| Phenobarbital Oral Solutionphenobarbital oral | Phenobarbital 20 mg/5mL | SolutionOral | PAI Holdings, LLC dba PAI Pharma | 0121-0942 | 00121-0942-1600121-0942-50 |